improvement of our Thanks, and particular. adjusted performance the and execution year the proud and profitability quarter I sales achieved half as EBITDA. the operational our in second we today's Tandem's returned call. on expectation business. in exceeded We everyone, Reflecting positive of am welcome, to our demonstrating to Susan, first the across while target
exceptional X the with integrations starting Tandem sensor of by innovations recently, and of of milestone for launch Tandem Source, the most We our clearance new progress new preparing the FDA exciting Mobi. also made product for rollout reaching
new segments their existing With digital delivering beyond optimize and care. solutions of customer are where additional these reach operate providing different X demonstrating they how today, products, our diabetes the to in in excellence into market we to we manage choice our and expanding new customers
in new with up sets for Reminiscent are devices exciting meet to of This having the Control-IQ when another first products reinforce market. period living of needs diabetes diverse the us of people portfolio fulfilling in in These and our that vision important the delivery. we a leadership unique also insulin company's of history, introduced automated
previously the that of during innovation of we discussed, turbulence wave be of highest launches customer the we to anticipate ensure term the we overall of second the level maintain XXXX. We market in year, into the in these this near the satisfaction scaling half months year the busiest that will and may throughout as create
it access new was t:slim for the customers XX purchasing before pricing promotional our than to of of backdrop, now new it With for and may year. deductibles we customers once impact relates timing remainder excitement purchasing program this building new $XXX it program clearance. introduced this becomes rather and Mobi particularly against decisions, Tandem have available a products Tandem Tandem broadly The is the to access the awareness weigh January. the for of Customer provides quickly in as Choice as $XXX Mobi to reset
with the new between of year. predict reduce the may This clears to said current seen the historically difficult the to the it's will sales product impact access time the this its the Having dynamic seamless product that, and helps and remainder availability. launches technologies that customers we've have provide for our FDA pausing on
reason, with guidance we XXXX, that competitive for and an increasingly starting reset our baseline and low prudent business. it's to a worldwide, environment the with in on focus For a expectations combination XXXX we while point for feel driving
for By establishing we so, sustainable pipeline. market-leading are growth, driven deliver doing path innovation a Tandem our by to
reputation experience system to services. This technology high-quality satisfaction. expand as stand in offerings the diabetes to rated of our terms offering solutions as on evident and we our fall, strong t:slim was in automated prepare of building this we're continues second XX As out #X overall quarter our and delivery decade the insulin customer
different with repeatedly having insertion reinforced angles the and infusion Association comfort directly in American spoke of and impact benefits health patients as Diabetes was Diego. here user how providers pump for the cannula recent the Providers materials took options I Scientific and place to experience. care importance their attachability their sets Sessions at San that patients of wearability, spoke This
and strategy they the our their comments importance and personalize multiple to system. customers how of need that of people enabling underscore These AID and that of systems aspects use wear they options recognizing how reinforce our
application Keep management global positive clinicians with Another highlight was Tandem was in of to data specifically mind, Source the our at demonstrations this that booth. mind. designed reaction in our is
they globally in June deploy comprehensive and so into it central out progress the plans months the data view thereafter. a our this country-by-country and insights a it began rolling launch provides basis with with We will reporting continue in to patient patients. States location on spot trends can these to to in use and critical United It coming put
Tandem Tandem For a be will by control even connected the which to with cloud Source offers and continuously Mobi, app. more meaningful smart mobile becomes HCPs, phone
see and this in customers For customers, streamline new adding important that trainings. and supply features enhancing platform the plan for experience it's to a build to around future we data, feature reordering by therapy our
level continue new likely launched States offerings partners high the entrants, currently experienced of the we that in of internationally. selling outside second quarter, some a both there's new the hearing have only more In activity distribution from against. diabetes U.S. began related is that United our which ADA and conference pump in as The to and we devices, about also pressure reinforced
with is an in meaningful. competition, the longer-term increase United our anticipated opportunity outside States Even
Control-IQ building t:slim has to in been XX shown Our still we immediate benefits awareness deliver early with and sustained of internationally. and populations, all stages are in the market
for pressures GX FreeStyle this product Libre increase the be the in t:slim term, the scaled beginning launch sensors we're new new advance X of own fall. Dexcom track integrations will United are that integrations. cautious our In external and may of launches, first which States with CGM near in XX a on
more decision that anticipate the that X sensor differentiator, a empowers user the users will be actions XX t:slim We interoperability will first not CGM Choice pump of sensor and integrations. to only a needs make it's is preferences. CGM true and best for than and the realization FDA-cleared their offer of
technologies first these systems and customers CGMs want market of We to of new is our It commitment with latest our to evidence have and a lot the and lead the takes being access of integration. to our CGM benefits new people systems launch their I'd partnership continued coordination an for of with AID more and like diabetes. their and to the Dexcom thank benefits to for Abbott as partnership systems. even to we living bring CGM integrated collaboration enable
computer. Libre in planning QX be QX. broadly be broadly integration Freestyle the Dexcom in-warranty international in the first all integrations launches X. for middle customers followed of will will to to and be FreeStyle we The GX by States, are In charge and updates for for be GX These be with of completed can part and offered the available a these to X DexCom personal Libre pump available from United integration software no
am as first delivery and likely therapy. of and to the automated pump living segment people in otherwise of of Mobi durable the technologies next expansion our smallest innovation. Redefined is to not way opportunity to the with new is pump world's a system. an Mobi diabetes, creating clearance a Turning devices new would for particularly proud is is leading our this of therapy. choose Tandem insulin bring of our to pump hardware adopt whole benefit miniaturization, category durable offerings our who I to it family insulin
choose Already, making algorithm. reported iOS the its renewal was dynamic X/X decisions who #X that and AID In they await pausing availability level the their this of are own Mobi control of for our new and of we're purchasing rated customer planted with experiencing some our wear customers. our multiple that small nearly size, quarter, to hearing reported from even options, second and future Mobi discrete sales customers leadership greater
Mobi with in This plan QX, on off have of thousands even limited and and followed call in Mobi's kick release center on up grown XXXX. broad FDA our We more launch availability clearance our enthusiasm our early scale signed of has by to website for more information following through availability. early a people
of the in the seasonality maximize their business along that right, before the is new platform the The work time a the as Launching goes customers is year. help due and benefits quarter their from our of U.S. demand a to time they with education associated doing and and already high which it at team. period end takes talented to physician clinical typical insurance sales reset our fourth significant in customer
This period. important launch even Mobi this a scaled more making is why during available through is
offerings. our these beyond to Turning near-term pipeline
site infusion an includes We Mobi for feature hardware are wear and our portfolio, patch continuing infusion which development work set, durable tubeless XX, for pump. a and our the cartridge t:slim SIG, extended
second We people study in control type the includes for using X a arm quarter. with clinically, diabetes are of active also randomized very which a enrollment began Control-IQ,
study We in-human fourth the are for to wear set, infusion trial for for clinical of extended the and in begin this year. also study our quarter a preparing set, first
most to mission-driven can executing that excellence, management. company. which blocks our experience have our innovation, It's product you and are in and relentless we the see, part operational therapy are confident of commitment well insulin we portfolio revolutionary As are of customer building exciting
we in employees like delivering hard on their fortune of in positioning XXXX and work thank these Tandem for navigating for I'd success. the how passion our to quarter. second is The team's are each
on for provide and turn quarter year. the I'd like and that, Leigh more over to the guidance With our expectations to the call to information
you go, Here Leigh?